Antidepressants beneficial for women with postnatal depression
2015-05-19
(Press-News.org) Antidepressants are associated with better rates of treatment response and remission for women with postnatal depression, when compared to a placebo, according to a new systematic review by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London.
Reports often focus on the risks of using antidepressants during pregnancy and the postnatal period but this paper, published today in the Journal of the American Medical Association (JAMA), highlights the benefits that antidepressants can have for women with postnatal depression. Postnatal depression occurs in more than 10 per cent of mothers over the first year post-delivery.
Guidelines recommend psychological interventions for mild to moderate depression, and that the risk-benefit ratio of antidepressants (including SSRIs - selective serotonin re-uptake inhibitors) be considered before using them in the postnatal period, including the effect of medication on baby and mother and the likely benefit of psychological intervention.
A systematic review of six randomised controlled trials of 596 women found that antidepressants were of benefit for postnatal depression. The study included a meta-analysis, which involved pooling data from three of the trials. It found that of the 72 women with postnatal depression randomised to treatment with SSRIs, 54 per cent reported 'much improved' symptoms or a more than 50 per cent symptom reduction, compared to 36 per cent of those who were randomised to placebo.
Remission rates (i.e. no longer meeting validated criteria for depression) were also improved, with 49 per cent of participants randomised to SSRIs showing remission compared to 26 per cent in the placebo group. These findings related to a treatment period of between six to eight weeks.
Emma Molyneaux, first author from the IoPPN at King's College London, said:
'Our findings are important due to the limited research exploring the use of antidepressants to treat postnatal depression. We would urge that treatment decisions during the postnatal period consider the potential benefits as well as risks of medication, as well as the risks of untreated depression for both mother and baby.'
Kylee Trevillion, co-author and post-doctoral researcher at the IoPPN, said: 'There have been relatively few trials of antidepressants for postnatal depression and few studies to date have included women with severe depression. Postnatal depression impacts not only the mother but also the rest of the family - more research is needed in this area to improve outcomes for mothers and their families.'
NIHR-funded Professor Louise Howard, senior author from the IoPPN, said: 'Some antidepressants are safer than others for mothers who are breastfeeding, so mothers seeking advice for depressive symptoms should ensure that their doctor knows if they are breastfeeding.'
INFORMATION:
The authors of this study are funded by the Medical Research Council (MRC), Tommy's baby charity, the National Institute for Health Research (NIHR) and the NIHR Maudsley Biomedical Research Centre.
Paper reference: Molyneaux E, Trevillion K, Howard L M (2015) 'Antidepressant Treatment for Postnatal Depression'. JAMA
For further media information please contact Jack Stonebridge, Press Officer, Institute of Psychiatry, Psychology & Neuroscience, King's College London jack.stonebridge@kcl.ac.uk/ (+44) 020 7848 5377
About King's College London: http://www.kcl.ac.uk
King's College London is one of the top 20 universities in the world (2014/15 QS World University Rankings) and among the oldest in England. King's has more than 26,500 students (of whom nearly 10,400 are graduate students) from some 150 countries worldwide, and nearly 6,900 staff. The university is in the second phase of a £1 billion redevelopment programme which is transforming its estate.
King's has an outstanding reputation for world-class teaching and cutting-edge research. In the 2014 Research Excellence Framework (REF) King's was ranked 6th nationally in the 'power' ranking, which takes into account both the quality and quantity of research activity, and 7th for quality according to Times Higher Education rankings. Eighty-four per cent of research at King's was deemed 'world-leading' or 'internationally excellent' (3* and 4*). The university is in the top seven UK universities for research earnings and has an overall annual income of more than £600 million.
King's has a particularly distinguished reputation in the humanities, law, the sciences (including a wide range of health areas such as psychiatry, medicine, nursing and dentistry) and social sciences including international affairs. It has played a major role in many of the advances that have shaped modern life, such as the discovery of the structure of DNA and research that led to the development of radio, television, mobile phones and radar.
King's College London and Guy's and St Thomas', King's College Hospital and South London and Maudsley NHS Foundation Trusts are part of King's Health Partners. King's Health Partners Academic Health Sciences Centre (AHSC) is a pioneering global collaboration between one of the world's leading research-led universities and three of London's most successful NHS Foundation Trusts, including leading teaching hospitals and comprehensive mental health services. For more information, visit: http://www.kingshealthpartners.org.
King's fundraising campaign - World questions|King's answers - created to address some of the most pressing challenges facing humanity has reached its £500 million target 18 months ahead of schedule. The university is now aiming to build on this success and raise a further £100 million by the end of 2015, to fund vital research, deliver innovative new treatments and to support scholarships. The campaign's five priority areas are neuroscience and mental health, leadership and society, cancer, global power and children's health. More information about the campaign is available at http://www.kcl.ac.uk/kingsanswers.
About National Institute for Health Research
The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government's strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website (http://www.nihr.ac.uk).
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-19
Researchers determined DNA sequences from the Y chromosomes of 334 men belonging to 17 populations from Europe and the Middle East
Study shows that almost two out of three (64%) modern European men belong to just three young paternal lineage
Male-specific population expansion was widespread, and surprisingly recent, focusing interest on the Bronze Age
Geneticists from the University of Leicester have discovered that most European men descend from just a handful of Bronze Age forefathers, due to a 'population explosion' several thousand years ago.
The project, which ...
2015-05-19
The leading theory for why the blood of younger mice rejuvenates the muscles of older mice is now in contest. The vampiric exchange of young blood and old blood has long been reported to have anti-aging effects, but it was in 2013 when Harvard University researchers first linked GDF-11, a molecule that circulates in the blood, to this effect.
Now, an analysis that set out to see how GDF-11 works in the muscles published May 19 in Cell Metabolism found just the opposite. The investigators showed first that GDF-11 was not specifically measured; the methods that were previously ...
2015-05-19
Chicago -- May 14, 2015 -- Infants undergoing some types of surgery could have better recovery if they receive regional anesthesia rather than general anesthesia, according to two studies published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists® (ASA®). Researchers explored the differences between the two types of anesthesia by measuring the presence of apnea, a breathing complication, following hernia surgery.
Experts have long examined the effects of anesthesia on infants and toddlers, ...
2015-05-19
With the help of a computer program called "Rosetta," researchers at Vanderbilt University have "redesigned" an antibody that has increased potency and can neutralize more strains of the AIDS-causing human immunodeficiency virus (HIV) than can any known natural antibody.
Their findings, published online today in The Journal of Clinical Investigation, suggest that computer-redesigned antibodies may speed the search for an effective therapy or vaccine for a virus that so far has eluded all attempts to eradicate it.
"There's a consensus (in the HIV field) that the vaccine ...
2015-05-19
WASHINGTON --The best remedy for severe salicylate poisoning is hemodialysis, according to a comprehensive systematic review of the medical literature published on Friday in Annals of Emergency Medicine ("Extracorporeal Treatment for Salicylate Poisoning: Systematic Review and Recommendations from the EXTIRP Workgroup"). Salicylate is an active ingredient in aspirin as well as hundreds of over-the-counter medications, and contributes to approximately 20,000 accidental or intentional poisonings and nearly 30 deaths reported to US Poison Control Centers every year.
"Our ...
2015-05-19
Using nature for inspiration, a team of Northwestern University scientists is the first to develop an entirely artificial molecular pump, in which molecules pump other molecules. This tiny machine is no small feat. The pump one day might be used to power other molecular machines, such as artificial muscles.
The new machine mimics the pumping mechanism of life-sustaining proteins that move small molecules around living cells to metabolize and store energy from food. For its food, the artificial pump draws power from chemical reactions, driving molecules step-by-step from ...
2015-05-19
JACKSONVILLE, Fla. -- Patients with liver cancer can be cured with a liver transplant. But because of the shortage of donated organs, these patients often die waiting for a liver. That's because most transplant centers predominantly use livers from donors who die from brain death.
But in the largest study of its kind, transplant physicians at Mayo Clinic in Florida have found that liver cancer patients have the same beneficial outcomes using organs donated by patients who died of cardiac death. The study was recently published online in the American Journal of Transplantation.
MULTIMEDIA ...
2015-05-19
(New York, May 19, 2015) -- The largest urban health systems, which serve as safety nets for large patient populations with lower socioeconomic status and greater likelihood to speak English as a second language, do worse on government patient satisfaction scores than smaller, non-urban hospitals likely to serve white customers with higher education levels, according to a new study by Mount Sinai researchers published this month in the Journal of Hospital Medicine.
Patient satisfaction scores, in part due to the Affordable Care Act of 2010, are a key part of the formula ...
2015-05-19
ANN ARBOR--A class of FDA-approved cancer drugs may be able to prevent problems with brain cell development associated with disorders including Down syndrome and Fragile X syndrome, researchers at the University of Michigan Life Sciences Institute have found.
The researchers' proof-of-concept study using fruit fly models of brain dysfunction was published today in the journal eLife. They show that giving the leukemia drugs nilotinib or bafetinib to fly larvae with the equivalent of Fragile X prevented the wild overgrowth of neuron endings associated with the disorder. ...
2015-05-19
For the patient, surgery involves extreme physical stress, and in older patients especially this can lead to disorders of consciousness or cognition. The acute confusional state known as delirium, however, can often be prevented by specialist nursing care after the operation, as Torsten Kratz and co-authors show in an original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 289-96). In their study delirium liaison nurses were employed to help care for surgical patients aged 70 years and over. In every patient, the risk ...
LAST 30 PRESS RELEASES:
[Press-News.org] Antidepressants beneficial for women with postnatal depression
